Markets › United States › NAS › IPHA

Innate Pharma SA

NAS:IPHAHealthcarenasdaq_composite

$1.55+6.16%LiveIn session · ≈ AED 5.69 · Market cap $173.5M · Next earnings Thu 25 Mar

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	28.8%	−184.1%	10.4%	10.8%	100.0%	100.0%	—	—
Operating margin	1.5%	−394.9%	−99.6%	−24.4%	−408.6%	−1,916.9%	−1,916.9%	+0.0 pts
Net margin	−91.7%	−436.0%	−100.7%	−14.6%	−392.0%	−1,764.5%	−271.6%	+1492.9 pts
EBITDA margin	19.1%	−356.9%	−21.3%	−3.5%	−371.7%	−1,566.1%	—	—
Return on equity	−41.0%	−49.2%	−107.3%	−14.6%	−560.0%	226.7%	34.9%	−191.8 pts
Return on assets	−20.8%	−19.7%	−28.0%	−4.3%	−44.5%	−78.4%	−12.1%	+66.4 pts
Return on capital employed	0.4%	−25.5%	−34.5%	−9.3%	−66.1%	−205.0%	—	—
Debt / equity	0.1×	0.4×	0.8×	0.8×	3.5×	−1.0×	−1.0×	+0.0%
Debt / assets	6.2%	16.5%	20.3%	22.8%	27.9%	36.0%	—	—
Interest coverage	3.2×	−153.3×	−199.4×	−19.8×	−91.1×	−121.4×	—	—
Current ratio	3.8×	1.7×	3.4×	3.7×	2.6×	1.3×	1.3×	+0.0%
Quick ratio	3.7×	1.7×	3.4×	3.7×	2.6×	1.3×	—	—
Cash ratio	3.0×	1.3×	2.0×	1.8×	2.0×	0.8×	0.8×	+0.0%
Asset turnover	0.2×	0.0×	0.3×	0.3×	0.1×	0.0×	—	—
Inventory turnover	15.1×	—	—	—	—	—	—	—
Receivables turnover	6.2×	7.3×	18.4×	1.1×	7.7×	0.4×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—